SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Lead Poisoning D007855 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Fatty Liver D005234 48 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Li R et al. Puerarin exerts the protective effect against chemical induced dysmetabolism in rats. 2016 Gene pmid:27677221
Loutchanwoot P et al. Evaluation of in vivo estrogenic potency of natural estrogen-active chemical, puerarin, on pituitary function in gonadectomized female rats. 2016 Life Sci. pmid:27615593
Tanaka T et al. Anti-Hyperglycemic Effect of a Kudzu (Pueraria lobata) Vine Extract in Ovariectomized Mice. 2016 J. Nutr. Sci. Vitaminol. pmid:27928122
Zhang Y et al. Puerarin Prevents LPS-Induced Osteoclast Formation and Bone Loss via Inhibition of Akt Activation. 2016 Biol. Pharm. Bull. pmid:27904045
Liao ZG et al. Improvement of Transmembrane Transport Mechanism Study of Imperatorin on P-Glycoprotein-Mediated Drug Transport. 2016 Molecules pmid:27886150
Ji Y et al. Anticerebral Ischemia-Reperfusion Injury Activity of Synthesized Puerarin Derivatives. 2016 Biomed Res Int pmid:27807543
Zhang D et al. The Neuroprotective Effect of Puerarin in Acute Spinal Cord Injury Rats. 2016 Cell. Physiol. Biochem. pmid:27576607
Zhang L et al. Puerarin transport across a Calu-3 cell monolayer - an in vitro model of nasal mucosa permeability and the influence of paeoniflorin and menthol. 2016 Drug Des Devel Ther pmid:27468226
Wang K et al. Neuroprotective Effect of Puerarin on Glutamate-Induced Cytotoxicity in Differentiated Y-79 Cells via Inhibition of ROS Generation and Ca(2+) Influx. 2016 Int J Mol Sci pmid:27409614
Wu H et al. Puerarin Exerts an Antiinflammatory Effect by Inhibiting NF-kB and MAPK Activation in Staphylococcus aureus-Induced Mastitis. 2016 Phytother Res pmid:27335240
Chen J et al. Puerarin affects bone biomarkers in the serum of rats with intrauterine growth restriction. 2016 J Tradit Chin Med pmid:27400476
Wang S et al. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition. 2016 Int. Immunopharmacol. pmid:27318789
Su B et al. Relevance of the Pharmacokinetic and Pharmacodynamic Profiles of Puerariae lobatae Radix to Aggregation of Multi-Component Molecules in Aqueous Decoctions. 2016 Molecules pmid:27367654
Xu X et al. Puerarin, isolated from Pueraria lobata (Willd.), protects against diabetic nephropathy by attenuating oxidative stress. 2016 Gene pmid:27317894
Zhang X et al. Puerarin Attenuates Cardiac Hypertrophy Partly Through Increasing Mir-15b/195 Expression and Suppressing Non-Canonical Transforming Growth Factor Beta (Tgfβ) Signal Pathway. 2016 Med. Sci. Monit. pmid:27145790
Xiong N et al. hVMAT2: A Target of Individualized Medication for Parkinson's Disease. 2016 Neurotherapeutics pmid:27137201
Wang C et al. Puerarin attenuates inflammation and oxidation in mice with collagen antibody-induced arthritis via TLR4/NF-κB signaling. 2016 Mol Med Rep pmid:27278131
Cheng Y et al. Protective Effect of Puerarin Against Oxidative Stress Injury of Neural Cells and Related Mechanisms. 2016 Med. Sci. Monit. pmid:27074962
Liu G et al. Recent Advances in Methods of Puerarin Biotransformation. 2016 Mini Rev Med Chem pmid:27145856
Saraswat G et al. Molecular cues to the anti-implantation effect of nano-puerarin in rats. 2016 Reproduction pmid:27026713
Wang Q et al. WITHDRAWN: Puerarin injection for unstable angina pectoris. 2016 Cochrane Database Syst Rev pmid:27136749
Xue Q et al. Lyophilized Powder of Catalpol and Puerarin Protects Neurovascular Unit from Stroke. 2016 Int. J. Biol. Sci. pmid:27019622
Wang ZK et al. Alleviation of Lead-Induced Apoptosis by Puerarin via Inhibiting Mitochondrial Permeability Transition Pore Opening in Primary Cultures of Rat Proximal Tubular Cells. 2016 Biol Trace Elem Res pmid:27116952
Ma Y et al. Puerarin Attenuates Anoxia/Reoxygenation Injury Through Enhancing Bcl-2 Associated Athanogene 3 Expression, a Modulator of Apoptosis and Autophagy. 2016 Med. Sci. Monit. pmid:27011313
Luo X et al. Puerarin Exerts a Delayed Inhibitory Effect on the Proliferation of Cardiomyocytes Derived from Murine ES Cells via Slowing Progression through G2/M Phase. 2016 Cell. Physiol. Biochem. pmid:27008508
Hu Y et al. Inhibitory effect of puerarin on vascular smooth muscle cells proliferation induced by oxidised low-density lipoprotein via suppressing ERK 1/2 phosphorylation and PCNA expression. 2016 Pharmazie pmid:27004373
Jiang QD and Li XP Effect of puerarin on the expression of NMU, NPY, and POMC genes in the hypothalamus. 2016 Genet. Mol. Res. pmid:26985919
Yuan SY et al. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. 2016 Chin J Nat Med pmid:27114313
Qu H et al. Rapid lateral-flow immunoassay for the quantum dot-based detection of puerarin. 2016 Biosens Bioelectron pmid:26991602
Su HF et al. Absorptive interactions of concurrent oral administration of (+)-catechin and puerarin in rats and the underlying mechanisms. 2016 Acta Pharmacol. Sin. pmid:26972494
Liu B et al. Puerarin for ischaemic stroke. 2016 Cochrane Database Syst Rev pmid:26891451
Xu X et al. Puerarin reduces apoptosis in rat hippocampal neurons culturea in high glucose medium by modulating the p38 mitogen activated protein kinase and c-Jun N-terminal kinase signaling pathways. 2016 J Tradit Chin Med pmid:26946623
Hong XP et al. Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain. 2016 J. Alzheimers Dis. pmid:26890737
Li W et al. Puerarin Improves Diabetic Aorta Injury by Inhibiting NADPH Oxidase-Derived Oxidative Stress in STZ-Induced Diabetic Rats. 2016 J Diabetes Res pmid:26881260
Suthon S et al. Anti-osteoporotic effects of Pueraria candollei var. mirifica on bone mineral density and histomorphometry in estrogen-deficient rats. 2016 J Nat Med pmid:26815435
Chang BY et al. Protective activity of kudzu (Pueraria thunbergiana) vine on chemically-induced hepatotoxicity: in vitro and in vivo studies. 2016 BMC Complement Altern Med pmid:26825303
Qiao L et al. A HPLC-MS/MS method for determination of 6'''-feruloylspinosin in rat plasma and tissues: Pharmacokinetics and tissue distribution study. 2016 J Pharm Biomed Anal pmid:26780157
Zhao YZ et al. Using PG-Liposome-Based System to Enhance Puerarin Liver-Targeted Therapy for Alcohol-Induced Liver Disease. 2016 AAPS PharmSciTech pmid:26753818
Huang FJ and Chan WH Apoptotic effects on maturation of mouse oocytes, fertilization and fetal development by puerarin. 2016 Drug Chem Toxicol pmid:26712108
Cheng G et al. Preparation and In Vitro/In Vivo Evaluation of Puerarin Solid Self-Microemulsifying Drug Delivery System by Spherical Crystallization Technique. 2016 AAPS PharmSciTech pmid:26694058
Liu X et al. Puerarin ameliorates cognitive deficits in streptozotocin-induced diabetic rats. 2016 Metab Brain Dis pmid:26686502
Liu CM et al. Puerarin protects mouse liver against nickel-induced oxidative stress and inflammation associated with the TLR4/p38/CREB pathway. 2016 Chem. Biol. Interact. pmid:26607348
Zhang H et al. Puerarin Inhibits oxLDL-Induced Macrophage Activation and Foam Cell Formation in Human THP1 Macrophage. 2015 Biomed Res Int pmid:26576421
Wu S et al. Study of the Biotransformation of Tongmai Formula by Human Intestinal Flora and Its Intestinal Permeability across the Caco-2 Cell Monolayer. 2015 Molecules pmid:26501241
Yin M et al. Puerarin Suppresses the Self-Renewal of Murine Embryonic Stem Cells by Inhibition of REST-MiR-21 Regulatory Pathway. 2015 Cell. Physiol. Biochem. pmid:26330232
Wang D et al. Automated On-Line Microdialysis Sampling Coupled with HPLC for Synchronous Determination of Puerarin in Subcutaneous Tissue and Plasma Following Topical Administration. 2015 Clin. Lab. pmid:26554250
Wang D et al. Evaluation of kudzu root extract-induced hepatotoxicity. 2015 J Ethnopharmacol pmid:26545459
Liu S et al. Puerarin attenuates severe burn-induced acute myocardial injury in rats. 2015 Burns pmid:26514700
Zhao SS et al. Puerarin attenuates learning and memory impairments and inhibits oxidative stress in STZ-induced SAD mice. 2015 Neurotoxicology pmid:26511841
Bao L et al. The anti-atherosclerotic effects of puerarin on induced-atherosclerosis in rabbits. 2015 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:24510110